Skip to main content
. 2020 Sep 1;15(19):1834–1853. doi: 10.1002/cmdc.202000502

Table 1.

Affinities of hydroxylated and fluorinated perhydroquinoxalines and reference compounds towards KOR and related receptors.

graphic file with name CMDC-15-1834-g014.jpg

Compd.

R1

R2

Ki±SEM [nM]/% inhibition at 1 μM[a,b]

KOR

MOR

DOR

σ1

σ2

[3H]U‐69,593

[3H]DAMGO

[3H]DPDPE

(+)‐[3H]pentazocine

[3H]DTG

1a13

CO2C(CH3)3

H

3.8±1.2

260

438

12 %

16 %

1b13

H

H

0.54±0.15

28 %

205

0 %

5 %

1c13

CO2CH3

H

1.3±0.4

0 %

250

0 %

8 %

12 a

CO2C(CH3)3

(S)−OH

16±2

9 %

5 %

0 %

0 %

12 b

H

(S)−OH

2.0±0.5

29 %

246

2 %

0 %

12 c

CO2CH3

(S)−OH

9.2±6.0

5 %

693

0 %

5 %

14 b

H

(R)−F

1.5±0.4

2 %

251

0 %

0 %

14 c

CO2CH3

(R)−F

0.82±0.69

0 %

12 %

8 %

962

U‐50,488

0.34±0.07

Naloxone

7.3±0.40

2.3±1.1

103

Morphine

5.2±1.6

SNC80

1.2±0.5

(+)‐pentazocine

5.4±0.5

Haloperidol

6.6±0.9

78±2.3

[a] A value in % reflects the inhibition of the radioligand binding at a test compound concentration of 1 μM. K i values without SEM values represent the mean of two experiments (n=2) and K i values with SEM values represent the mean of three experiments (n=3). [b] Guinea pig brain membrane preparations were used in the KOR, MOR and σ1 assay. In the DOR assay rat brain and in the σ 2 assay rat liver membrane preparations were used.